Tesamorelin + Ipamorelin
3.3mg/3.3mg/ml 3mls (10mg + 10mg vial) $137 [15-60 Injections]
Growth Hormone Support | Visceral Fat Research | Body Composition | Metabolic Health
What Is Tesamorelin + Ipamorelin?
Tesamorelin and Ipamorelin are two synthetic peptides that work through different pathways to stimulate the body's natural production of growth hormone (GH).
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that signals the pituitary gland to release growth hormone. It has been studied extensively for its effects on visceral fat, body composition, and metabolic health.
Ipamorelin is a growth hormone secretagogue that activates receptors involved in growth hormone release, supporting the body's natural growth hormone signaling pathways.
When combined, these peptides target two complementary pathways involved in growth hormone production. Growth hormone plays an important role in fat metabolism, muscle maintenance, tissue repair, and overall metabolic function.
Areas of Research & Potential Benefits
Visceral Fat Reduction
Tesamorelin has demonstrated the ability to reduce visceral adipose tissue (VAT), the deeper abdominal fat surrounding internal organs, in adults with HIV-associated lipodystrophy. Researchers are interested in how growth hormone-related pathways influence abdominal fat distribution and metabolic health.
Growth Hormone Production
Both peptides stimulate growth hormone release through different mechanisms. Their complementary actions have generated interest in their potential effects on natural growth hormone secretion.
Fat Metabolism & Body Composition
Growth hormone plays a role in lipolysis, the process of breaking down stored fat for energy. Researchers have explored the relationship between growth hormone signaling, fat distribution, and the maintenance of lean body mass.
Muscle Maintenance & Recovery
Growth hormone and IGF-1 contribute to protein metabolism, muscle maintenance, and normal tissue repair processes. These pathways are being investigated for their potential influence on muscle health and recovery.
Metabolic Health
Tesamorelin has been studied for its effects on abdominal fat distribution and liver fat in certain patient populations. Researchers have also investigated how growth hormone signaling influences glucose metabolism, insulin sensitivity, and overall metabolic function.
Sleep & Recovery
Growth hormone is naturally released in pulses, with significant secretion occurring during deep sleep. Researchers have explored the relationship between growth hormone activity, sleep physiology, and the body's natural recovery processes.
Healthy Aging & Hormonal Changes
Growth hormone production naturally declines with age. Growth hormone-releasing peptides have attracted research interest for their potential influence on age-related changes in metabolism, body composition, and tissue maintenance.
Who Should Avoid Tesamorelin + Ipamorelin?
Individuals with the following conditions should avoid this combination or undergo medical evaluation before considering growth hormone-related therapies:
-
Pregnancy or breastfeeding: Use should be avoided.
-
Active cancer: Growth hormone and IGF-1 signaling may influence tumor growth.
-
History of cancer: Requires individualized medical evaluation.
-
Pituitary or hypothalamic disorders: Certain conditions affecting the growth hormone pathway are contraindications to tesamorelin.
-
Diabetes or elevated blood sugar: Growth hormone activity may worsen glucose tolerance.
-
Elevated IGF-1 levels: Additional stimulation of the growth hormone pathway may be inappropriate.
-
Significant cardiovascular disease: Fluid retention and metabolic changes may be a concern.
-
Children and adolescents: Use requires specialist evaluation.
Potential Side Effects
Possible side effects may include:
- Injection-site redness, swelling, or irritation
- Headaches
- Flushing
- Nausea
- Fluid retention or swelling
- Joint or muscle discomfort
- Carpal tunnel symptoms
- Changes in blood glucose levels
- Increased IGF-1 levels
- Allergic reactions
Important Information
Tesamorelin is an FDA-approved active ingredient in certain prescription products for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for general weight loss.
Ipamorelin is an investigational peptide and is not FDA-approved.
The combined Tesamorelin + Ipamorelin formulation is not FDA-approved. Its safety and effectiveness have not been established.
Ordering Information
Please note: You will not be charged for the peptide when checking out through our website.
Once your order has been submitted, you will receive a follow-up email with additional information regarding the peptide, the consultation process, and the next steps.
All requests are subject to appropriate medical review and applicable prescribing requirements. Submitting an order does not guarantee approval or fulfillment.